-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, HSCs, survivorship, aplastic anemia, bacterial, bone marrow, Diseases, Non-Biological, Bone Marrow Failure, chemical interactions, Diamond Blackfan Anemia, platelets, Therapies, Adverse Events, chemotherapy, Fanconi Anemia, Genetic Disorders, Pediatric, red blood cells, Biological Processes, white blood cells, immune cells, Technology and Procedures, Young Adult, Cell Lineage, immunotherapy, Infectious Diseases, erythropoiesis, Study Population, Clinically relevant, genetic profiling, genomics, hematopoiesis, pharmacology, Quality Improvement , transplantation, inflammation, molecular testing, NGS, microenvironment, WGS, pathways, senescence, signal transduction
Monday, December 7, 2020: 7:00 AM-3:30 PM

Deena Iskander, MD1*, Guanlin Wang, PhD2*, Elisabeth F Heuston, PhD3*, Chrysi Christodoulidou1*, Bethan Psaila, MD4, Mark E Robinson, PhD1*, Aristeidis Chaidos, MD, PhD1*, Pritesh Trivedi, MSc5*, Nikolaos Trasanidis, PhD1*, Alexia Katsarou, MD1*, Richard Szydlo, PhD6*, NISC Comparative SequencingProgram7*, Qais Al-Oqaily, MD, PhD6*, Valentina S Caputo, PhD1*, Kanagaraju Ponnusamy, PhD1*, Anindita Roy, MD, PhD8, Leena Karnik, FRCPath, MRCP9*, Kikkeri Naresh, MD5*, Adam J. Mead, MD, PhD4, Supat Thongjuea, PhD2*, Marjorie Brand, PhD10*, Josu de la Fuente6,11, David M Bodine, PhD3, Irene Roberts, MD, PhD12 and Anastasios Karadimitris, MD, PhD1*

1Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
2MRC WIMM Centre for Computational Biology, University of Oxford, U.K, Oxford, United Kingdom
3NHGRI, National Institutes of Health, Bethesda, MD
4MRC Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
5Department of Histopathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
6Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
7NHGRI, Bethesda
8Department of Paediatrics, University of Oxford, Oxford, United Kingdom
9Department of Paediatrics, St. Mary's Hospital, London, United Kingdom
10Ottawa Hospital Research Institute, Ottawa, ON, Canada
11Department of Paediatrics, St. Mary's Hospital/Imperial College London, London, United Kingdom
12Department of Paediatrics and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford, United Kingdom

Marcus A Florez, BS1,2, Katie A Matatall, PhD1,3,4,5*, Youngjae Jeong, PhD6*, Laura Ortinau, PhD7*, Paul Shafer, BS8*, Anne Lynch, BS9*, Roman Jaksik, PhD10*, Marek Kimmel, PhD, DSc10*, Dongsu Park, PhD7,11* and Katherine Y. King, MD, PhD1,2,4,11

1Pediatric Infectious Diseases, Baylor College of Medicine, Houston, TX
2Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX
3Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX
4Stem Cells and Regenerative Medicine Center/Pediatric Infectious Diseases, Baylor College of Medicine, Houston, TX
5Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
6Human and Molecular Genetics, Baylor College of Medicine, Houston, TX
7Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
8Immunology, Baylor College of Medicine, Houston, TX
9Developmental Biology, Baylor College of Medicine, Houston, TX
10Department of Statistics, Rice University, Houston, TX
11Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX

Fengkui Zhang1*, Guangxin Peng1*, Guangsheng He, MD, PhD2*, Hong Chang3*, Sujun Gao4*, Xinjian Liu5*, Tong Chen, MD, PhD6, Pei Li7*, Bing Han8*, Miao Miao9*, Zheng Ge, MD, PhD10, Xiaoyan Ge11*, Fei Li12*, Yingmei Li13*, Shunqing Wang14*, Yi Wang, MD15*, Yaqi Shen16*, Yanfei Tai16*, Tao Zhang16*, Bo Zhu16* and Jianjun Zou16*

1Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
2Jiangsu Province Hospital, Nanjing, China
3West China Hospital of Sichuan University, Chengdu, China
4Jilin University, First Hospital of Bethune Medical, Changchun, China
5Henan Cancer Hospital, Zhengzhou, China
6Division of Hematology, Huashan Hospital of Fudan University, Shanghai, China
7Huashan Hospital Affiliated to Fudan University, Shanghai, China
8Peking Union Medical College Hospital, Beijing, China
9The First Affiliated Hospital of Suzhou University, Suzhou, China
10Zhongda Hospital Affiliated to Southeast University, Nanjing, China
11The Second Hospital of Shanxi Medical University, Taiyuan, China
12The First Affiliated Hospital of Nanchang University, Nanchang, China
13The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
14Guangzhou First People's Hospital, Guangzhou, China
15Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, China
16Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China

Burak Altintas, MD1, Neelam Giri, MD2, Lisa J. McReynolds, MD, PhD3 and Blanche P. Alter, MD, MPH1

1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
3NCI, National Institutes of Health, Bethesda, MD

Georgina L Ryland, PhD1,2, Lucy C Fox, MBBS1,2,3, Xiangting Chen, PhD1*, Satwica Yerneni, MS1*, Jeffrey Szer, MBBS4, Ashish Bajel, FRACP1, Robin J Filshie, MBChB, PhD, FRACP, FRCPA5, Sue Morgan, FRACP, FRCPA, MBBS6*, Sarah-Jane Dawson, MD, PhD1,2* and Piers Blombery, MBBS1,2,7*

1Peter MacCallum Cancer Centre, Melbourne, Australia
2University of Melbourne, Melbourne, Australia
3Monash University, Melbourne, Australia
4Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, VIC, Australia
5St. Vincent's Hospital Melbourne, Melbourne, Australia
6Alfred Hospital, Melbourne, Australia
7Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Hind Alotaibi, MBBS1, Mahmoud Aljurf2, Regis Peffault De Latour, MD, PhD3*, Shahid Iqbal4*, Andrea Bacigalupo5, Judith Marsh6, Hubert Schrezenmeier7, Eliane Gluckman8,9*, Mansour Alfayez1*, Britta Hoechsmann7*, Constantijn Halkes10, Josu de la Fuente11, Nawal AlShehry1*, Simone Cesaro12*, Jakob Passweg13*, Carlo Dufour14, Antonio Risitano, MD, PhD15, John F. DiPersio, MD16 and Ibraheem Motabi1*

1King Fahad Medical City, Riyadh, Saudi Arabia
2King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
3Saint-Louis Hospital, Paris, France
4Manchester Royal Infirmary, Manchester, United Kingdom
5Universita’ Cattolica del Sacro Cuore, Roma, Italy
6King’s College Hospital/King’s College London, London, United Kingdom
7University Hospital Ulm, Ulm, Germany
8Eurocord, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
9Monacord, Centre Scientifique de Monaco, Principauté de Monaco, Monaco, France
10Leiden University Medical Centre, Leiden, Netherlands
11Imperial College Healthcare/Imperial College London, London, United Kingdom
12Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
13University Hospital Basel, Basel, Switzerland
14Hematology Unit, G Gaslini Children Research Hospital, Genova, Italy
15Hematology and BMT Unit, Moscati Hospital, Avellino, Italy
16Washington University School of Medicine, St. Louis, Missouri

Mark C Wilkes, PhD1, Kavitha Siva, PhD2*, Jacqueline D Mercado3, Ethan Patrick Wentworth1*, Mallika Saxena1*, Jun Chen, MD, PhD2*, Anupama Narla, MD1, Bertil Glader, MD, PhD1, Shuo Lin, PhD4*, Manuel Serrano, PhD5*, Johan Flygare, MD, PhD2 and Kathleen M. Sakamoto, MD, PhD1

1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
2Molecular Medicine and Gene Therapy, Lund Strategic Center for Stem Cell Biology, Lund University, Lund, Sweden
3Michigan State University College of Human Medicine, East Lansing
4Department of Molecular, Cell & Developmental Biology, University of California, Los Angeles, Los Angeles, CA
5Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain

Adam Wahida1*, Stephan Hutter, PhD2*, Manja Meggendorfer, PhD2, Cassandra M. Kerr, MS3*, Carmelo Gurnari, MD3*, Elisabeth Weiss, PhD2*, Claudia Haferlach, MD2, Wolfgang Kern, MD2, Jaroslaw P. Maciejewski, MD, PhD4 and Torsten Haferlach, MD2

1Torsten Haferlach Leukaemiediagnostik Stiftung, Munich, Germany
2MLL Munich Leukemia Laboratory, Munich, Germany
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Motoharu Hamada1*, Hideki Muramatsu, MD, PhD2, Yusuke Okuno, MD, PhD3, Ayako Yamamori, MD4*, Taro Yoshida, MD4*, Masayuki Imaya, MD4*, Manabu Wakamatsu, MD1*, Shunsuke Miwata, MD1*, Kotaro Narita, MD, PhD1*, Daisuke Ichikawa, MD1*, Rieko Taniguchi, MD, PhD1*, Atsushi Narita, MD, PhD5*, Nozomu Kawashima, MD, PhD1*, Eri Nishikawa, MD, PhD1*, Nobuhiro Nishio, MD, PhD1,6*, Asahito Hama, MD, PhD7*, Masafumi Ito, MD, PhD8*, Tomoo Ogi, Ph.D.9*, Seiji Kojima, MD, PhD1* and Yoshiyuki Takahashi, MD, PhD1*

1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Nagoya University Graduate School of Medicine, Nagoya, Japan
3Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan
4Pediatrics, Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Department of Pediatrics, Graduate School of Medicine, Nagoya University, Nagoya, Japan
6Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
7Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
8Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
9Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan

Wei Zuo1*, Bo Zhang2*, Jing Ruan3*, Miao Chen4*, Jian Li, MD5 and Bing Han, MD/PhD6*

1Department of pharmacy, Perking Union Medical College Hospital, Beijing, China
2Department of pharmayc, Perking Union Medical College Hospital, Beijing, China
3Department of Hematology, Perking Union Medical College Hospital, Beijing, China
4Department of Hematology, Peking Union Medical Colleague Hospital, Beijing, CHN
5Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
6Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Irina N. Shipounova, PhD1*, Alyona I. Dorofeeva2*, Nikolay M. Kapranov3*, Anton V. Luchkin, MD3*, Zalina T. Fidarova, MD PhD3*, Elena A Mikhailova, PhD, MD4* and Valeriy G. Savchenko, MD, PhD5

1Physiology of Hematopoiesis Lab, National Research Center for Hematology, Moscow, Russia
2Physiology of Hematopoiesis Lab, National Research Center for Hematology, Moscow, Russian Federation
3National Research Center for Hematology, Moscow, Russian Federation
4National Scientific Center for Hematology, Moscow, RUS
5National Research Center for Hematology, Moscow, Russian Federation, Moscow, Russian Federation

Amye M. Harrigan, BSc, MD1*, Shelley MacDonald, MSc, CGC, CCGC2*, Bruce N. Crooks, ChB, BSc, MRCPCH, MRCP(UK)3*, Sarah Dyack, MD, FRCPC, FCCMG2,4* and Amy M. Trottier, MSc, MD, FRCPC5

1Department of Medicine, Dalhousie University, Saint John, NB, Canada
2Maritime Medical Genetics, IWK Health Centre, Halifax, NS, Canada
3Department of Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, CAN
4Department of Pediatric Medical Genetics, IWK Health Centre, Halifax, NS, Canada
5Department of Hematology, QEII Health Science Centre, Halifax, NS, Canada

Daphna Nachmani1*, Lourdes M. Mendez, MD, PhD2 and Pier Paolo Pandolfi, MD, PhD3

1Silberman Institute for Life Science, The Hebrew University, Jerusalem, Israel
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA, Boston, MA

*signifies non-member of ASH